Jazz Pharmaceuticals Plc - Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Jazz Pharmaceuticals, Inc. on June 1, 2009. The filing discloses the entry into a material definitive agreement regarding the company's principal executive offices located at 3180 Porter Drive, Palo Alto, California.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a lease amendment. The filing details the following rental cost adjustments effective September 1, 2009:
- Current Monthly Rent: $67,964
- Year 1 (Sept 2009 - Aug 2010): $65,772.00 per month
- Year 2 (Sept 2010 - Aug 2011): $74,541.60 per month
- Year 3 (Sept 2011 - Aug 2012): $78,926.40 per month
Material Changes
The primary material change is the extension of the Commercial Lease with Wheatley-Fields, LLC (successor to The Board of Trustees of the Leland Stanford Junior University) by 36 months. The lease term, which was set to expire on September 1, 2009, is now extended through August 31, 2012. The agreement includes two consecutive renewal options for two-year periods, subject to prevailing market rent.
Outlook and Risks
The filing contains no management guidance, outlook, or discussion of general business risks. The only contingency noted is the potential exercise of renewal options, which would adjust the base rent to prevailing market rates as determined by the lease terms.
Investor Verification Points
- Verify the total annualized cost impact of the lease extension compared to the previous rate.
- Confirm the availability of the two consecutive two-year renewal options and the mechanism for determining "prevailing market rent."
- Review the full text of the First Amendment of Lease filed as Exhibit 10.86 for any additional covenants or obligations not summarized in the 8-K.